|
Uniphar PLC on Tuesday highlighted ‘particularly robust demand’ in the Global Sourcing business at Uniphar Pharma, as it posted a profit surge and a higher dividend. The Dublin-based healthcare services company said pretax profit jumped 23% to €28.7 million in the first half of 2025 from €23.4 million a year prior. Adjusted earnings per share jumped 21% to 9.8c from 8.1c, while basic EPS rose 18% to 6.6c from 5.6c. The company said this was helped by the impact of a lower interest rate environment. Earnings before interest, tax, depreciation and amortisation grew 2.9% to €57.5 million from €55.9 million. Revenue climbed 8.6% to €1.5 million from €1.4 million. The company noted organic gross profit growth of 8.1%, amid an 18% organic gross profit surge in Uniphar Pharma which had ‘particularly robust demand’ in the Global Sourcing business. Uniphar declared an interim dividend of 0.71 euro cents per share, up 6.0% from 0.67c a year ago. Looking ahead, the company said it entered the second half of the year with ‘strong’ trading momentum. For 2025, Uniphar expects organic gross profit growth across all divisions to be in line with medium-term targets, noting it is positioned to deliver on market expectations of double-digit adjusted EPS growth for the year. The company aims for Ebitda to grow to €200 million by 2028, with at least 80% of that increase to be delivered organically. Uniphar shares fell 1.1% to 349.00 pence each on Tuesday morning in London. Copyright 2025 Alliance News Ltd. All Rights Reserved.
|
